Similar changes in marker expressed were observed at flare onset versus baseline in flare patients, with increased expression of HLA-DR, CD38 and GZMH, and reduced expression of IL7R (Supplementary Fig. 4B), again corroborating an increased activation and effector phenotype of these cells in RA flare. This evidence concerns the gene CD38 and rheumatoid arthritis.